Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Ustekinumab safely and effectively. See full prescribing information for USTEKINUMAB. Ustekinumab® (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Ustekinumab is indicated for the treatment of adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Ustekinumab is indicated for the treatment of adults and pediatric patients 6 years of age and older with active psoriatic arthritis. Ustekinumab is indicated for the treatment of adults and pediatric patients 2 years of age and older with moderately to severely active Crohn's disease. Ustekinumab is indicated for the treatment of adults and pediatric patients 2 years of age and older with moderately to severely active ulcerative colitis.
- generic_name
- ustekinumab
- product_names
- ustekinumab
- ndc
- 57894-440, 57894-441, 57894-444, 57894-440-03, 57894-440-01, 57894-441-01, 57894-444-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en